Claris Injectables Limited

Activity by year

20162017201820192020202120222023202420252026

Acquisition

Jul 27, 2017ACQUISITIONIndia$625.0M
Baxter completes acquisition of Claris Injectables for $625 million
Baxter International Inc. completed the acquisition of Claris Injectables Limited, a global generic injectables pharmaceutical company, for approximately $625 million, gaining three manufacturing plants and over 50 products.
Baxter International acquirer Claris Injectables Limited target #Medical Devices baxter.com.pl biopharmadive.com
Dec 15, 2016ACQUISITIONAhmedabad, India, India$625.0M
Baxter to acquire Claris Injectables for $625 million
Baxter International entered a definitive agreement to acquire Claris Injectables Limited, a subsidiary of Claris Lifesciences, for approximately $625 million. The deal is expected to close in the second half of 2017.
Baxter International acquirer Claris Injectables Limited target Claris Lifesciences Limited partner Claris Lifesciences Limited target #Medical Devices baxter.ca timesofindia.indiatimes.com

Acquired by

Loading…